[Ip-health] Lancet Oncology Comment on new WHO Essential Cancer Drugs

Ophira Ginsburg ophiraginsburg at gmail.com
Sat Jul 13 03:50:45 PDT 2019


Brilliant Ellen.
Well done!
Ophira 

> On Jul 13, 2019, at 12:43 AM, Ellen 't Hoen <ellenthoen at medicineslawandpolicy.net> wrote:
> 
> Dear IP-Health readers,
> 
> Yesterday, the Lancet Oncology published a comment we wrote on the addition of 10 (12 if you count the alternatives) cancer medicines to the WHO Model List of Essential Medicines and the need for action at international and national level to ensure these medicines are available and affordable for people with cancer.
> 
> You can access the paper here:
> https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30459-0/fulltext
> 
> Kind regards,
> 
> Ellen ‘t Hoen
> ————————————————————
> Ellen ‘t Hoen LLM, PhD | Medicines Law & Policy
> www.medicineslawandpolicy.org
> E-mail: ellenthoen at medicineslawandpolicy.net
> Twitter: @ellenthoen
> 
> _______________________________________________
> Ip-health mailing list
> Ip-health at lists.keionline.org
> http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org



More information about the Ip-health mailing list